Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $89.9400 (-1.38%) ($89.0100 - $91.0200) on Thu. Jan. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 17 | Latest Price | $89.9400(-1.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.3% a day on average for past five trading days. | Weekly Trend | LGND declines -5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(58%) IWC(55%) XBI(55%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.165% in a week (0% probabilities). VIXM(-33%) VXX(-20%) TLT(-14%) UUP(-5%) SHY(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 0 () | Intraday Trend | -1.2% | | | |
|
1 - 5 Day Possible Target | $80.4(-10.61%) | Resistance Level | $97.03 | 5 Day Moving Average | $90.76(-0.9%) | 10 Day Moving Average | $91.39(-1.59%) | 20 Day Moving Average | $97.03(-7.31%) | To recent high | -20.8% | To recent low | 0.2% | Market Cap | $1.445b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |